{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:58:42Z","timestamp":1790485122129,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.nbd.2019.104579","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T02:17:19Z","timestamp":1566440239000},"page":"104579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-5509","authenticated-orcid":false,"given":"Paolo","family":"Calabresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2921-8348","authenticated-orcid":false,"given":"David G.","family":"Standaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.104579_bb0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI90132","article-title":"Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson, disease therapy","volume":"127","author":"Alcacer","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.nbd.2019.104579_bb0020","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1523\/JNEUROSCI.2300-09.2009","article-title":"Cerebellothalamocortical connectivity regulates penetrance in dystonia","volume":"29","author":"Argyelan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104579_bb0030","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104579_bb0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.109.162396","article-title":"Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization","volume":"333","author":"Bordia","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.104579_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11065-010-9143-9","article-title":"The cerebellum and basal ganglia are interconnected","volume":"20","author":"Bostan","year":"2010","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.nbd.2019.104579_bb0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrn2337","article-title":"The pathophysiological basis of dystonias","volume":"9","author":"Breakefield","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/acn3.438","article-title":"Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study","volume":"4","author":"Brumberg","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.36.2.160","article-title":"Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl","volume":"36","author":"Burke","year":"1986","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104579_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0065","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","article-title":"Levodopa-induced dyskinesias in patients with Parkinson\u2019s disease: filling the bench-to-bedside gap","volume":"9","author":"Calabresi","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0070","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0184","article-title":"Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?","volume":"370","author":"Calabresi","year":"2015","journal-title":"Philos. Trans. Roy. Soc. B: Biol. Sci."},{"key":"10.1016\/j.nbd.2019.104579_bb0075","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nn.4306","article-title":"Hyperkinetic disorders and loss of synaptic downscaling","volume":"19","author":"Calabresi","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nn.2753","article-title":"The neural substrates of rapid-onset dystonia-parkinsonism","volume":"14","author":"Calderon","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12311-016-0763-3","article-title":"Consensus paper: towards a systems-level view of cerebellar function: the interplay between cerebellum, basal ganglia, and cortex","volume":"16","author":"Caligiore","year":"2017","journal-title":"Cerebellum."},{"key":"10.1016\/j.nbd.2019.104579_bb0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.21806","article-title":"Microstructural white matter changes in primary torsion dystonia","volume":"23","author":"Carbon","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e31827f0798","article-title":"Metabolic changes in DYT11 myoclonus-dystonia","volume":"80","author":"Carbon","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104579_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuron.2013.10.041","article-title":"Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry","volume":"81","author":"Cazorla","year":"2014","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104579_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2014.04.002","article-title":"Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia","volume":"77","author":"Cerovic","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2019.104579_bb0110","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/nn.3868","article-title":"Short latency cerebellar modulation of the basal ganglia","volume":"17","author":"Chen","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2014.01.011","article-title":"Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors","volume":"263","author":"Cote","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2019.104579_bb0120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11846","article-title":"Concurrent activation of striatal direct and indirect pathways during action initiation","volume":"494","author":"Cui","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104579_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuron.2004.06.028","article-title":"Mutations in the Na+\/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism","volume":"43","author":"de Carvalho Aguiar","year":"2004","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104579_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0135","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1523\/JNEUROSCI.0435-08.2008","article-title":"Corticostriatal and Thalamostriatal synapses have distinctive properties","volume":"28","author":"Ding","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.104579_bb0145","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.21-15-05546.2001","article-title":"Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane","volume":"21","author":"Dunah","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104579_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/mol.65.1.121","article-title":"Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32","volume":"65","author":"Dunah","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104579_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2015.02.002","article-title":"Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia","volume":"127\u2013128","author":"Eskow Jaunarajs","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104579_bb0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mds.26913","article-title":"Biomarker-driven phenotyping in Parkinson\u2019s disease: a translational missing link in disease-modifying clinical trials","volume":"32","author":"Espay","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0175","article-title":"Risk factors of levodopa-induced dyskinesia in Parkinson, disease: results from the PPMI cohort","volume":"4","author":"Eusebi","year":"2018","journal-title":"Npj Parkinson\u2019s disease"},{"key":"10.1016\/j.nbd.2019.104579_bb0180","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1212\/WNL.33.10.1255","article-title":"High dosage anticholinergic therapy in dystonia","volume":"33","author":"Fahn","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104579_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12311-015-0737-x","article-title":"Cerebellar and motor cortical transcranial stimulation decrease levodopa-induced dyskinesias in Parkinson\u2019s disease","volume":"15","author":"Ferrucci","year":"2016","journal-title":"Cerebellum."},{"key":"10.1016\/j.nbd.2019.104579_bb0190","first-page":"5","article-title":"Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia","author":"Fieblinger","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2019.104579_bb0195","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1523\/JNEUROSCI.0683-16.2016","article-title":"Dynamic DNA methylation regulates levodopa-induced dyskinesia","volume":"36","author":"Figge","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2015.06.004","article-title":"Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of rapid onset dystonia-parkinsonism","volume":"82","author":"Fremont","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0205","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22775","article-title":"A role for cerebellum in the hereditary dystonia DYT1","volume":"6","author":"Fremont","year":"2017","journal-title":"Elife."},{"key":"10.1016\/j.nbd.2019.104579_bb0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2015.11.022","article-title":"Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms","volume":"86","author":"Ghiglieri","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0215","doi-asserted-by":"crossref","first-page":"41156","DOI":"10.1038\/srep41156","article-title":"Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia","volume":"7","author":"Grutz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2019.104579_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson\u2019s disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2019.104579_bb0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","article-title":"Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson\u2019s disease","volume":"48","author":"Hallett","year":"2005","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.104579_bb0230","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuropharm.2010.12.032","article-title":"Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats","volume":"60","author":"Huang","year":"2011","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.104579_bb0235","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/brain\/awt147","article-title":"Defective cerebellar control of cortical plasticity in writer\u2019s cramp","volume":"136","author":"Hubsch","year":"2013","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104579_bb0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1353-8020(01)00025-6","article-title":"Dystonia and parkinsonism","volume":"8","author":"Jankovic","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0245","first-page":"1","article-title":"Post mortem studies in Parkinson disease is it possible to detect brain areas for specific symptoms?","author":"Jellinger","year":"1999","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2019.104579_bb0250","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.23401","article-title":"Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?","volume":"26","author":"Karimi","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fneur.2014.00157","article-title":"Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network","volume":"5","author":"Kishore","year":"2014","journal-title":"Front. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.104579_bb0260","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S1353-8020(13)70033-6","article-title":"Genetics in dystonia","volume":"20","author":"Klein","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0b013e3181ad5387","article-title":"Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease","volume":"73","author":"Koch","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104579_bb0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2012.11.018","article-title":"Optogenetic identification of striatal projection neuron subtypes during in vivo recordings","volume":"1511","author":"Kravitz","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104579_bb0275","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nn.3397","article-title":"Convergent cortical innervation of striatal projection neurons","volume":"16","author":"Kress","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0280","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2017.03.063","article-title":"Parkinsonism and dystonia are differentially induced by modulation of different territories in the basal ganglia","volume":"353","author":"Kumbhare","year":"2017","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104579_bb0285","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp.2003.020800","article-title":"Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson\u2019s disease","volume":"76","author":"Kuoppamaki","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2019.104579_bb0290","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2018.06.024","article-title":"Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: implications for L-DOPA-induced dyskinesia","volume":"138","author":"Lanza","year":"2018","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.104579_bb0295","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.10301","article-title":"Secondary cervical dystonia associated with structural lesions of the central nervous system","volume":"18","author":"LeDoux","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0300","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/exnr.1993.1064","article-title":"Cerebellectomy eliminates the motor syndrome of the genetically dystonic rat","volume":"120","author":"LeDoux","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.23400","article-title":"Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson\u2019s disease","volume":"26","author":"Lee","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00002826-198606000-00007","article-title":"Dystonia in Untreated Parkinsonism","volume":"9","author":"LeWitt","year":"1986","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2019.104579_bb0315","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1172\/JCI72830","article-title":"TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration","volume":"124","author":"Liang","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.nbd.2019.104579_bb2000","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.26009","article-title":"Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors","volume":"29","author":"Maltese","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0320","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33331","article-title":"Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum","volume":"7","author":"Maltese","year":"2018","journal-title":"eLife."},{"key":"10.1016\/j.nbd.2019.104579_bb0325","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/brain\/awp194","article-title":"Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine","volume":"132","author":"Martella","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104579_bb0330","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/brain\/awp194","article-title":"Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine","volume":"132","author":"Martella","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104579_bb0335","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2014.01.016","article-title":"Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia","volume":"65","author":"Martella","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0340","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00702-018-1846-8","article-title":"Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications","volume":"125","author":"Mellone","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2019.104579_bb0345","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fncel.2015.00245","article-title":"NMDA receptor GluN2A\/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients","volume":"9","author":"Mellone","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00245","article-title":"NMDA receptor GluN2A\/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients","volume":"9","author":"Mellone","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0355","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nbd.2018.09.021","article-title":"NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology","volume":"121","author":"Mellone","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2019.104579_bb0360","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12311-018-0981-y","article-title":"Modulatory effects of levodopa on cerebellar connectivity in Parkinson\u2019s disease","volume":"18","author":"Mueller","year":"2019","journal-title":"Cerebellum."},{"key":"10.1016\/j.nbd.2019.104579_bb0365","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jnnp.69.4.494","article-title":"Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia","volume":"69","author":"Munchau","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2019.104579_bb0370","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2010.03.003","article-title":"Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia","volume":"38","author":"Napolitano","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0375","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-4159.2008.05417.x","article-title":"Striatal histone modifications in models of levodopa-induced dyskinesia","volume":"106","author":"Nicholas","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104579_bb0380","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08352","article-title":"Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons","volume":"4","author":"Pappas","year":"2015","journal-title":"Elife."},{"key":"10.1016\/j.nbd.2019.104579_bb0385","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36691","article-title":"A cell autonomous torsinA requirement for cholinergic neuron survival and motor control","volume":"7","author":"Pappas","year":"2018","journal-title":"Elife."},{"key":"10.1016\/j.nbd.2019.104579_bb0390","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1523\/JNEUROSCI.5712-09.2010","article-title":"Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control Glutamatergic and cholinergic signaling","volume":"30","author":"Parikh","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0395","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0400","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awq342","article-title":"Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia","volume":"134","author":"Picconi","year":"2010","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104579_bb0405","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2006.07.006","article-title":"Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia","volume":"24","author":"Pisani","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0410","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0415","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410230112","article-title":"Dystonia in parkinson\u2019s disease: clinical and pharmacological features","volume":"23","author":"Poewe","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0420","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.25532","article-title":"Emerging concepts in the physiological basis of dystonia","volume":"28","author":"Quartarone","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0425","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bcp.2013.06.027","article-title":"Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice","volume":"86","author":"Quik","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104579_bb0430","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/brain\/awv212","article-title":"A new knock-in mouse model of l-DOPA-responsive dystonia","volume":"138","author":"Rose","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104579_bb0435","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2017.06.005","article-title":"Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia","volume":"295","author":"Scarduzio","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0440","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2009.01.001","article-title":"Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia","volume":"34","author":"Sciamanna","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024261","article-title":"Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia","volume":"6","author":"Sciamanna","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2019.104579_bb0450","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.nbd.2012.04.015","article-title":"Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA","volume":"47","author":"Sciamanna","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0455","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1523\/JNEUROSCI.0041-12.2012","article-title":"Cholinergic dysfunction alters synaptic integration between Thalamostriatal and Corticostriatal inputs in DYT1 dystonia","volume":"32","author":"Sciamanna","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pneurobio.2011.10.005","article-title":"Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson\u2019s disease","volume":"96","author":"Sgambato-Faure","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104579_bb0465","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1469-8749.1986.tb03909.x","article-title":"Acute dystonic reaction to bethanechol--a direct acetylcholine receptor agonist","volume":"28","author":"Shafrir","year":"1986","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0470","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12311-016-0825-6","article-title":"Current opinions and areas of consensus on the role of the cerebellum in dystonia","volume":"16","author":"Shakkottai","year":"2017","journal-title":"Cerebellum."},{"key":"10.1016\/j.nbd.2019.104579_bb0475","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2015.10.039","article-title":"M4 muscarinic receptor Signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia","volume":"88","author":"Shen","year":"2015","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104579_bb0480","doi-asserted-by":"crossref","first-page":"104462","DOI":"10.1016\/j.nbd.2019.05.001","article-title":"Dystonia and Parkinson\u2019s disease: what is the relationship?","volume":"132","author":"Shetty","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0485","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2011.01.012","article-title":"Update on the pathology of dystonia","volume":"42","author":"Standaert","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-328X(96)00117-9","article-title":"Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus","volume":"42","author":"Standaert","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2019.104579_bb0495","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.028","article-title":"Post-stroke movement disorders: the clinical, neuroanatomic, and demographic portrait of 284 published cases","volume":"27","author":"Suri","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pneurobio.2018.07.003","article-title":"Selective basal ganglia vulnerability to energy deprivation: experimental and clinical evidences","volume":"169","author":"Tambasco","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104579_bb0505","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2014.08.006","article-title":"Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models","volume":"71","author":"Thiele","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104579_bb0510","doi-asserted-by":"crossref","first-page":"vii7","DOI":"10.1007\/s00415-006-7003-6","article-title":"Dystonia in Parkinson disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2019.104579_bb0515","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/mds.25025","article-title":"Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson\u2019s disease","volume":"27","author":"Walker","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0520","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s13311-016-0426-6","article-title":"Deep brain stimulation for movement disorders of basal ganglia origin: restoring function or functionality?","volume":"13","author":"Wichmann","year":"2016","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.nbd.2019.104579_bb0525","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.2888-13.2014","article-title":"Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice","volume":"34","author":"Won","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104579_bb0530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jb\/mvm191","article-title":"Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice","volume":"143","author":"Yokoi","year":"2008","journal-title":"J. Biochem."},{"key":"10.1016\/j.nbd.2019.104579_bb0535","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pjnns.2017.11.004","article-title":"Comparison of dystonia between Parkinson\u2019s disease and atypical parkinsonism: the clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism","volume":"52","author":"Yoon","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.nbd.2019.104579_bb0540","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mds.25817","article-title":"ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson\u2019s disease","volume":"29","author":"Zhang","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0545","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.26453","article-title":"\u0152\u00b17 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage","volume":"30","author":"Zhang","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104579_bb0550","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnsys.2017.00043","article-title":"Evaluation of AZD1446 as a therapeutic in DYT1 dystonia","volume":"11","author":"Zimmerman","year":"2017","journal-title":"Front. Syst. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119302475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119302475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:17:14Z","timestamp":1760851034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119302475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":111,"alternative-id":["S0969996119302475"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104579","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104579"}}